Comorbidities Up Among Patients With ESRD, Concomitant Psoriasis
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — For patients with end-stage renal disease...
Read MoreAug 18, 2022
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — For patients with end-stage renal disease...
Read MoreAug 17, 2022
After receiving CD19 chimeric antigen receptor T-cell therapy (CART19), patients with relapsed or...
Read MoreAug 17, 2022
Adenovirus-based techniques (such ChAdOx1 nCov-19) are one of the unique platforms used for severe...
Read MoreAug 17, 2022
Finding ways to produce hematopoietic stem cells (HSCs) in vitro is a prominent area of study...
Read MoreAug 17, 2022
Antigen modulation places a limit on the longevity of remission after single-antigen focused...
Read MoreAug 17, 2022
The 3 main components of contemporary multiple myeloma (MM) therapy are immunomodulatory imide...
Read MoreAug 17, 2022
Immune thrombotic thrombocytopenic purpura (iTTP) can be treated with rituximab, an anti-CD20...
Read MoreAug 17, 2022
Cognitive impairment in adults with sickle cell disease (SCD) poses a serious morbidity concern....
Read MoreAug 17, 2022
Children with relapsed/refractory Acute Myeloid Leukemia continue to have dismal results, and...
Read MoreAug 17, 2022
In a recent article, researchers discussed how a unique hemoglobin-platelet index (HPI) based on...
Read MoreAug 16, 2022
TUESDAY, Aug. 16, 2022 (HealthDay News) — A diet high in n-3 polyunsaturated fatty acids...
Read MoreAug 16, 2022
TUESDAY, Aug. 16, 2022 (HealthDay News) — Pregnancy status does not affect survival after...
Read MoreAug 16, 2022
TUESDAY, Aug. 16, 2022 (HealthDay News) — Nearly three in 10 Medicare beneficiaries have at...
Read MoreAug 16, 2022
In diffuse large B-cell lymphoma (DLBCL), angiogenesis and MYC expression were associated with a...
Read MoreAug 16, 2022
Acute myeloid leukemia (AML) is characterized by abnormal phosphatidylinositol-3 kinase/protein...
Read MoreAug 16, 2022
Based on results from the phase 3, placebo-controlled JAKARTA trial in JAK inhibitor-naive MF and...
Read MoreAug 16, 2022
A set of uncommon, sometimes lethal lymphoproliferative illnesses is referred to as Castleman...
Read MoreAug 16, 2022
Multiple myeloma (MM) patients who have resistant or refractory disease need to be treated. For a...
Read MoreAug 16, 2022
The majority of patients with newly diagnosed multiple myeloma (MM) have immunoparesis, which is...
Read MoreAug 16, 2022
Recently released studies examined cutting-edge treatments for relapsed/refractory diffuse large...
Read More